Catalyst Wire Dossier Catalyst Wire Dossier

NNC0148-0287 C

Insulin 287 · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0148-0287 C, covering 2025-03-11 to 2025-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week [Phase 1]

See pricing